Did you try going from Lexapro to Citalopram (generic Celexa)?
Lexapro is Citalopram with an ineffective isomer washed out.
(What's that noise? Oh, it's the sound of pharm reps gasping, like vampires driving past a garlic field. No free lunches for this boy!)
No, no, this is not medical advice. It is sad commentary about the broken U.S. health care system.
-- because of cost --
Lexapro is the bread and butter of Forest Labs, and they are fighting generics with everything they've got, using their somewhat questionable patent as a club, and spreading incredible stinking mountains of Fear, Uncertainty and Doubt (FUD).
Forest Laboratories Wins Lexapro Suit Against TevaBy Joel Rosenblatt
July 13, 2006 (Bloomberg) -- Forest Laboratories Inc.'s patent for the antidepressant Lexapro is valid, a federal judge ruled. The shares of the company, which makes drugs that treat depression and Alzheimer's disease, surged as much as 18 percent after hours.
In a trial before U.S. District Judge Joseph Farnan Jr. in Wilmington, Delaware, Teva Pharmaceutical Industries Ltd.'s Ivax Corp. acknowledged that it infringes the 1994 patent, licensed by Forest from Denmark's H. Lundbeck A/S. Teva argued it should never have been issued.
Lexapro is New York-based Forest's biggest moneymaker, generating $2.08 billion in U.S. sales in the year ended November on 29.5 million prescriptions, according to court papers. Forest's sales in the year ended March 2005 were $3.11 billion.
"The court will enter judgment in favor of'' Forest Laboratories, Farnan wrote in his opinion today.
Forest initiated the legal dispute in 2003 with a lawsuit alleging infringement by Ivax. Invalidating Lexapro's patent would have allowed Ivax and Cipla Ltd. of India to sell a generic version of the drug.
http://www.bloomberg.com/apps/news?pid=20601103&sid=aTjLZcSfCZ8c&refer=us